Clinical Trials Directory

Trials / Sponsors / Aptabio Therapeutics, Inc.

Aptabio Therapeutics, Inc.

Individual · 7 registered clinical trials — 4 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Phase 1 Study of ABF-101 in Single- and Multiple-Ascending Doses
Age Related Macular Degeneration (ARMD), AMD - Age-Related Macular Degeneration
Phase 12026-02-01
RecruitingA Phase 1 Study of APX-343A as Monotherapy or in Combination With Pembrolizumab in Subjects With Advanced Soli
Advanced Solid Cancer, Advanced Solid Tumor (Phase 1)
Phase 12025-10-24
RecruitingEfficacy and Safety Study of Isuzinaxib in Subjects With DKD
Diabetic Kidney Disease (DKD)
Phase 22025-05-26
RecruitingStudy of APX-115 in Contrast Induced Acute Kidney Injury in Subjects Undergoing PCI
Contrast Induced Acute Kidney Injury
Phase 22023-12-27
TerminatedA Phase 2 Study of APX-115 in Hospitalized Patients With Confirmed Mild to Moderate COVID-19.
COVID-19
Phase 22021-10-20
CompletedSafety, Tolerability and Renal Effects of APX-115 in Subjects With Type 2 Diabetes and Nephropathy
Diabetic Nephropathies, Diabetes Mellitus, Type 2, Nephropathy, Diabetic
Phase 22020-08-24
CompletedSafety, Tolerability, PK and PD of SAD or MAD of APX-115 in Healthy Male Volunteers
Healthy, Safety
Phase 12018-05-28